SCOPUS 정보 검색 플랫폼

Anticancer Research

Volumn 21, Issue 2 B, 2001, Pages 1475-1479

Oral estramustine therapy in serum Chromogranin A-positive stage D3 prostate cancer patients

(4) Zaky Ahel, M a Kovacic, K a Kraljic, I a Tarle, M a

a NONE (Croatia)

Author keywords

Estramustine therapy; Prostate cancer; Serum chromogranin A; Stage D3

Indexed keywords

CHROMOGRANIN A; ESTRAMUSTINE;

ARTICLE; BONE SCINTISCANNING; CANCER HORMONE THERAPY; CANCER STAGING; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SERODIAGNOSIS;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, HORMONAL; CHROMOGRANIN A; CHROMOGRANINS; ESTRAMUSTINE; HUMANS; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 0035002396 PISSN: 02507005 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (13)

References (25)

1
- 0025253720
- Unusual prostatic carcinomas
- (1990) Path Res Pract , vol.186 , pp. 28-35
- Dhom, G.¹

2
- 0024477771
- Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland
- (1989) Prostate , vol.14 , pp. 71-81
- Abrahamsson, Pt.A.¹ Lilja, H.²

3
- 0032535477
- Neuroendocrine or immune mediators in prostate cancer progression
- (1998) Front Biosci , vol.3
- Hoosein, N.M.¹

4
- 0026642686
- Neuroendocrine differentiation of carcinoma of the prostate
- (1992) Cancer , vol.70 , pp. 254-268
- Di Sant'Agnese, P.A.¹

5
- 0034131990
- Androgen deprivation in the prohormone convertase-310 human prostate cancer model system induces neuroendocrine differentiation
- (2000) Cancer Res , vol.60 , pp. 741-748
- Jongsma, J.¹ Oomen, M.N.² Noordzij, M.A.³ Van Weerden, W.M.⁴ Martens, G.J.⁵ Van der Kwast, T.H.⁶ Schroeder, F.H.⁷ Van Steenhrugge, G.J.⁸

6
- 0023481234
- Xenografted small-cell undifferentiated cancer of the prostate: Possible common origin with prostatic adenocarcinoma
- (1987) Prostate , vol.11 , pp. 271-283
- Van Haaften-Day, C.¹ Raghaven, D.² Russell, P.³ Wills, E.J.⁴ Gregory, P.⁵ Tilley, W.⁶ Horsfall, D.J.⁷

7
- 0024335391
- Site-specific growth of the prostate xenograft line UCRU-PR-2
- (1987) Prostate , vol.13 , pp. 163-173
- Jelbart, M.E.¹ Russell, P.J.² Russell, P.³ Wass, J.⁴ Fullerton, N.⁵ Wills, E.J.⁶ Raghaven, D.⁷

8
- 0026587323
- Small cell anaplastic carcinoma of the prostate: A clinical, pathological and immunohistochemical study of 27 patients
- (1992) J Urol , vol.147 , pp. 804-810
- Oesterling, J.¹ Hauzeur, C.² Farrow, G.³

9
- 0031890327
- Serum Chromogranin A (1998) Early detection of hormonal resistance in prostate cancer patients
- (1998) J Clin Lab Analysis , vol.12 , pp. 20-25
- Wu, J.T.¹ Astill, M.E.² Liu, G.H.³ Stephenson, R.A.⁴

10
- 0028567767
- Immunohistochemical staining and serotest markers during development of a sarcomatoid and small-cell prostate tumor
- (1994) Anticancer Res , vol.14 , pp. 2151-2156
- Frkovic-Grazio, S.¹ Kraljic, I.² Trnski, D.³ Tarle, M.⁴

11
- 0004950759
- Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo
- th Congress of European Society for Urological Research, Istanbul, October 5-7
- (2000) Europ Urol , vol.38 , pp. 531
- Burchardt, M.¹ Burchardt, T.² Pulte, T.³ De la Taille, A.⁴ Shabsigh, A.⁵ Buttyan, R.⁶

12
- 0031115334
- Neuroendocrine cells in the prostatic carcinomas after neoadjuvant therapy
- (1997) Kobe J Med Sci , vol.43 , pp. 71-81
- Chen, X.¹ Okada, H.² Gotoh, A.³ Arakawa, S.⁴ Kamidono, S.⁵

13
- 0026355799
- Elevated plasma chromogranin-A concentrations in prostatic carcinoma
- (1994) J Urol , vol.146 , pp. 358-361
- Kadmon, D.¹ Thompson, T.C.² Lynch, G.R.³ Scardino, P.T.⁴

14
- 0033368088
- Serum Chromogranin A in monitoring metastatic prostate cancer patients
- (1999) Anticancer Res , vol.19 , pp. 5663-5666
- Tarle, M.¹

15
- 0034213145
- Circulating neuroendocrine markers in patients with prostate carcinoma
- (2000) Cancer , vol.88 , pp. 2590-2597
- Berutti, A.¹ Dogliotti, L.² Mosca, A.³ Bellina, M.⁴ Mari, M.⁵ Torta, M.⁶ Tarabuzzi, R.⁷ Bollito, E.⁸ Fontana, D.⁹ Angeli, A.¹⁰

16
- 0032698866
- Different patterns of serum Chromogranin A in patients with prostate cancer with and without undergoing hormonal therapy
- (1999) J Clin Lab Anal , vol.13 , pp. 308-311
- Wu, J.T.¹ Wu, T.L.² Chang, C.P.³ Tsao, K.C.⁴ Sun, C.F.⁵

17
- 0001821225
- Serum Chromogranin A (ChrA) level vs. false negative %F-PSA data in prostate cancer diagnosis
- th Congress of European Society for Urological Research, Istanbul, October 5-7
- (2000) Europ Urol , vol.38 , pp. 505
- Tarle, M.¹

18
- 0004924198
- Management of hormone escaped prostate cancer
- Mosby, London
- (1996) Prostate Cancer , pp. 1143-1154
- Kirby, R.S.¹ Christmas, T.J.² Brawer, M.³

19
- 0001600522
- Chemotherapy for advanced prostate cancer
- 2000 Education book, May 19-23, 2000, New Orleans
- (2000) th Annual Meeting American Society of Clinical Oncology , pp. 585-594
- Smith, D.C.¹

20
- 0023553021
- Neuroendocrine differentiation in prostatic carcinoma
- (1987) Hum Path , vol.18 , pp. 849-855
- Di Sant Agnese, P.A.¹ De Mesy Jansen, K.L.²

21
- 0004930476
- Neuroendocrine differentiation in, prostatic carcinoma: An update
- (1988) Prostate (Suppl.B) , vol.74 , pp. 9-19
- Di Sant Agnese, P.A.¹

22
- 0028302956
- A more objective staging of advanced prostate cancer. Routine recognition of malignant endocrine structures: The assessment of serum TPS, PSA and NSE values
- (1994) Prostate , vol.24 , pp. 143-114
- Tarle, M.¹ Frkovic-Grazio, S.² Kraljic, I.³ Kovacic⁴

23
- 0033213779
- Synergistic effect of estramustine and (3′-keto-Btml)-(Val2)-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cells
- (1999) Biochem Pharmacol , vol.58 , pp. 1115-1121
- Wang, L.G.¹ Liu, X.M.² Budman, D.R.³ Kreis, W.⁴

24
- 0032761807
- Chemotherapy for advanced hormone refractory, prostate cancer
- (1999) Urology , vol.54 , Issue.6 A SUPPL. , pp. 30-35
- Petrylak, D.P.¹

25
- 0033962683
- Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
- (2000) Prostate , vol.42 , pp. 274-279
- Ahlgren, G.¹ Pedersen, K.² Lundberg, S.³ Aus, G.⁴ Hugosson, J.⁵ Abrahamsson, P.A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.